Novel Strategies for Preventing Fungal Infections Outline
Preprint
- 19 December 2024
- preprint
- Published by MDPI AG in Preprints.org
Abstract
Fungal infections are a significant global health challenge, causing approximately 3.8 million deaths annually, with immunocompromised populations particularly at risk. Traditional antifungal therapies, including azoles, echinocandins, and polyenes, face limitations due to rising antifungal resistance, toxicity, and inadequate treatment options. This review explores innovative strategies for preventing and managing fungal infections, such as vaccines, antifungal peptides, nanotechnology, probiotics and immunotherapy. Vaccines offer promising avenues for long-term protection, despite difficulties in development due to fungal complexity and immune evasion mechanisms. Antifungal peptides provide a novel class of agents with broad-spectrum activity and reduced resistance risk, whilst nanotechnology enables targeted, effective drug delivery systems. Probiotics show potential in preventing fungal infections, particularly vulvovaginal candidiasis, by maintaining microbial balance. Immunotherapy leverages immune system modulation to enhance antifungal defences, and omics technologies deliver comprehensive insights into fungal biology, paving the way for novel therapeutic and vaccine targets. While these approaches hold immense promise, challenges such as cost, accessibility, and translational barriers remain. A coordinated effort among researchers, clinicians, and policymakers is critical to advancing these strategies and addressing the global burden of fungal infections effectively.Keywords
All Related Versions
- Version 1, 2024-12-19, Preprints
- Published version: Pathogens, 14 (2), 126.
This publication has 101 references indexed in Scilit:
- Current trends, limitations and future research in the fungi?Fungal Diversity, 2024
- Recent drug development and treatments for fungal infectionsBrazilian Journal of Microbiology, 2023
- Immunotherapy as an Antifungal Strategy in Immune Compromised HostsCurrent Clinical Microbiology Reports, 2020
- Immunization and Vaccination2019
- Probiotics for vulvovaginal candidiasis in non-pregnant womenCochrane Database of Systematic Reviews, 2017
- Comparing the Recurrence of Vulvovaginal Candidiasis in Patients Undergoing Prophylactic Treatment with Probiotic and Placebo During the 6 MonthsProbiotics and Antimicrobial Proteins, 2016
- Probiotic lactobacilli inhibit early stages of Candida albicans biofilm development by reducing their growth, cell adhesion, and filamentationApplied Microbiology and Biotechnology, 2016
- Kidney Disease Caused by Therapeutic Agents2014
- Amphotericin B Formulations: A Comparative Review of Efficacy and ToxicityDrugs, 2013
- Multifunctional cationic host defence peptides and their clinical applicationsCellular and Molecular Life Sciences, 2011